HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 15 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
MYO18A
myosin XVIIIA
Chromosome 17 · 17q11.2
NCBI Gene: 399687Ensembl: ENSG00000196535.20HGNC: HGNC:31104UniProt: A0A994J771
137PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
ATP hydrolysis activityADP bindingactin filament bindingGolgi organizationcancerchronic myelogenous leukemialeukemiamyelodysplastic syndrome
✦AI Summary

MYO18A (myosin XVIIIA) is a structural myosin that lacks active ATPase-driven motor activity, functioning instead as an organizing protein in diverse cellular compartments 1. At the trans-Golgi network, MYO18A complexes with GOLPH3 to promote vesicle budding and facilitate Golgi-to-plasma membrane trafficking 2. The protein also participates in a complex with LURAP1 and MRCK that regulates retrograde actin treadmilling crucial for cell migration and protrusion 2. In immune regulation, MYO18A suppresses macrophage inflammatory responses by modulating CD14 trafficking and serves as a receptor for surfactant-associated protein A, enabling clearance of opsonized pathogens 3. Additionally, MYO18A enhances natural killer cell cytotoxicity and is involved in innate immune receptor trafficking on macrophages 4. Dysregulation of MYO18A is associated with multiple diseases: its fusion with FGFR1 occurs in myeloproliferative neoplasms 5, elevated serum levels correlate with poor prognosis in acute myeloid leukemia 6, and it functions in cholangiocarcinoma progression through interactions with Smad4 and PP1A 7. MYO18A genetic variants were also identified in Ménière's disease pathogenesis 8.

Sources cited
1
MYO18A lacks active ATPase-driven motor activity and functions as a structural myosin essential for organization and maturation of contractile machinery; dysregulation associated with cancer and myopathies
PMID: 32451870
2
MYO18A contains an N-terminal PDZ domain; functions in complex with GOLPH3 at trans-Golgi to promote vesicle budding; participates in retrograde actin treadmilling complex with LURAP1 and MRCK
PMID: 28942352
3
MYO18A regulates trafficking and expression of innate immune receptors on macrophages and suppresses inflammatory responsiveness via CD14 trafficking modulation
PMID: 25965346
4
MYO18A strongly enhances natural killer cell cytotoxicity
PMID: 27467939
5
MYO18A-FGFR1 fusion occurs in myeloproliferative neoplasms as a non-receptor-type FGFR kinase
PMID: 27245147
6
Higher serum levels of MYO18A correlate with poor overall survival in acute myeloid leukemia patients
PMID: 36919644
7
MYO18A interacts with PP1A via its RVFFR motif and with Smad4 via CC domain; coexpression of MYO18A and Smad4 indicates favorable prognosis in cholangiocarcinoma
PMID: 34799729
8
MYO18A variants were identified as high-priority genes in Ménière's disease pathogenesis, enriched in genes implicated in hearing loss and cochlear function
PMID: 38943082
Disease Associationsⓘ20
cancerOpen Targets
0.61Moderate
chronic myelogenous leukemiaOpen Targets
0.37Weak
acute lymphoblastic leukemiaOpen Targets
0.37Weak
leukemiaOpen Targets
0.37Weak
myelodysplastic syndromeOpen Targets
0.37Weak
major depressive disorderOpen Targets
0.28Weak
obsessive-compulsive disorderOpen Targets
0.28Weak
Tourette syndromeOpen Targets
0.28Weak
anorexia nervosaOpen Targets
0.27Weak
attention deficit hyperactivity disorderOpen Targets
0.27Weak
autism spectrum disorderOpen Targets
0.27Weak
bipolar disorderOpen Targets
0.27Weak
schizophreniaOpen Targets
0.27Weak
aortic diseaseOpen Targets
0.23Weak
Abnormality of the skeletal systemOpen Targets
0.18Weak
Abnormal facial shapeOpen Targets
0.12Weak
hydrops fetalisOpen Targets
0.12Weak
Multiple joint contracturesOpen Targets
0.12Weak
prostate cancerOpen Targets
0.12Weak
Familial prostate cancerOpen Targets
0.11Weak
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
FGFR1Protein interaction89%ZMYM2Protein interaction87%TRIM24Protein interaction87%CEP43Protein interaction87%FGFR1OP2Protein interaction87%ETV6Protein interaction86%
Tissue Expression6 tissues
Heart
100%
Liver
77%
Bone Marrow
55%
Brain
49%
Lung
33%
Ovary
25%
Gene Interaction Network
Click a node to explore
MYO18AFGFR1ZMYM2TRIM24CEP43FGFR1OP2ETV6
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt Q92614
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
0.41Moderately Constrained
pLIⓘ
1.00Intolerant
Observed/Expected LoF0.34 [0.28–0.41]
RankingsWhere MYO18A stands among ~20K protein-coding genes
  • #3,383of 20,598
    Most Researched137 · top quartile
  • #2,152of 17,882
    Most Constrained (LOEUF)0.41 · top quartile
Genes detectedMYO18A
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
Myosin XVIII.
PMID: 32451870
Adv Exp Med Biol · 2020
1.00
2
FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).
PMID: 27245147
Int J Mol Med · 2016
0.90
3
The Smad4-MYO18A-PP1A complex regulates β-catenin phosphorylation and pemigatinib resistance by inhibiting PAK1 in cholangiocarcinoma.
PMID: 34799729
Cell Death Differ · 2022
0.80
4
MYO18A: An unusual myosin.
PMID: 28942352
Adv Biol Regul · 2018
0.70
5
[Dermatomyositis and Autoantibodies].
PMID: 29632290
Brain Nerve · 2018
0.60